Dec 29 (Reuters) - Regeneus Ltd RGS.AX
* Regeneus collaborates with agc asahi for exclusive manufacture of progenza stem cell technology for Japanese market
* Regeneus and AGC establish 50/50 joint venture for exclusive clinical development and commercialisation of progenza
* regeneus to receive us$16.5m with us$5.5m upfront and us$11m in specified milestone payments Source text for Eikon: ID:nASX7PM7vl Further company coverage: RGS.AX